← back to search
Rose Hurren
University Health Network ·
Area of research
Molecular Biology · Hematology
Research interest
Research interests include Acute Myeloid Leukemia Research, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, and Ubiquitin and proteasome pathways.
h-index
43
citations
5,838
works
186
NIH funding
—
primary concept
Biology
email
✉ Find email ↗
Recent publications
IPO11 regulates the nuclear import of BZW1/2 and is necessary for AML cells and stem cells
Leukemia
2022
cited by
11
position: middle
doi
A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia
Cancer Medicine
2016
cited by
77
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Aaron D. Schimmer
· The University of Texas MD Anderson Cancer Center
2
papers (2016–2022)
Marcela Gronda
· University Health Network
2
papers (2016–2022)
Mark D. Minden
· Toronto Public Health
2
papers (2016–2022)
—
·
1
papers (2022–2022)
Joseph Brandwein
· Alberta Hospital Edmonton
1
papers (2016–2016)
—
·
1
papers (2022–2022)
Gary J. Schiller
· APLA Health
1
papers (2016–2016)
Brian Raught
· University Health Network
1
papers (2022–2022)
Nadav Segev
· Hebrew University of Jerusalem
1
papers (2022–2022)
Karen Yee
· University Health Network
1
papers (2016–2016)
Jonathan St‐Germain
· Hospital for Sick Children
1
papers (2022–2022)
Nathan Duong
· University Health Network
1
papers (2022–2022)
Vikas Gupta
· University Health Network
1
papers (2016–2016)
Razqallah Hakem
· University Health Network
1
papers (2022–2022)
Aisha Shamas‐Din
· McMaster University
1
papers (2016–2016)
Andrea Arruda
· Research Canada
1
papers (2022–2022)
Dilshad H. Khan
· University Health Network
1
papers (2022–2022)
Xiaoming Wang
· Wannan Medical College
1
papers (2022–2022)
Neil MacLean
· Princess Margaret Cancer Centre
1
papers (2022–2022)
Changjiang Xu
· University of Toronto
1
papers (2022–2022)